SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045340
Filing Date
2024-11-14
Accepted
2024-11-14 07:30:26
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1128551
2 ex31-1.htm EX-31.1 15264
3 ex31-2.htm EX-31.2 11437
4 ex32.htm EX-32 12647
  Complete submission text file 0001493152-24-045340.txt   6539707

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20240930.xsd EX-101.SCH 49843
6 XBRL CALCULATION FILE abeo-20240930_cal.xml EX-101.CAL 68950
7 XBRL DEFINITION FILE abeo-20240930_def.xml EX-101.DEF 204010
8 XBRL LABEL FILE abeo-20240930_lab.xml EX-101.LAB 457655
9 XBRL PRESENTATION FILE abeo-20240930_pre.xml EX-101.PRE 365235
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1013572
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 241457204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)